Archive
Past newsletters of MDDR.
Loading the archive
Past newsletters of MDDR.
Past newsletters of MDDR.
Wednesday, 29 July 2026
The European Medicines Agency has authorised Itvisma, a gene therapy for treating spinal muscular atrophy (SMA) in patients aged 2 years and
Tuesday, 28 July 2026
The Medical Board of Australia is developing new guidance for prescribing off-label, unapproved, and compounded medicines in response to the
Monday, 27 July 2026
Heart disease remains the leading cause of premature death globally. A new biography, 'Climbing Mountains: The Journey to Beat the World's B
Sunday, 26 July 2026
The second Lancet Commission on adolescent health and wellbeing emphasises the importance of addressing health during adolescence as a criti
Saturday, 25 July 2026
AHPRA's internal review revealed that 92% of the 477 notifications related to racism and discrimination were closed without regulatory actio
Friday, 24 July 2026
The Australian Medical Students Association (AMSA) expressed disappointment after the federal government excluded medical students from the
Thursday, 23 July 2026
The Australian Alliance for Artificial Intelligence in Healthcare warns that reliance on overseas-controlled AI systems could jeopardise the
Wednesday, 22 July 2026
The US Food and Drug Administration (FDA) has approved the first over-the-counter continuous glucose monitor (CGM) specifically for children
Tuesday, 21 July 2026
The Australian Medical Association (AMA) has revised its position on the role of doctors for the first time since 2011, explicitly addressin
Monday, 20 July 2026
The PARTNERS trial has commenced to evaluate treatments for Bundibugyo virus infection. This trial aims to address the challenges of treatin